| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.09. | AI Goes All In To Support Nursing Teams: Ambient Charting is Just the Start | ||
| 24.09. | UHC, Cigna and Centene Sign On to New National Shared Credentialing Program | ||
| 24.09. | Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact | ||
| 24.09. | From OpenNotes to "Doc Can I Record You?" Why Physicians Should Embrace Era of Accountability | ||
| 24.09. | Modernizing Medicare Advantage for the Next Generation of Seniors | ||
| 24.09. | Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease' | ||
| 23.09. | Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device | ||
| 23.09. | Who is Abridge's CEO Shiv Rao? No, Really… | ||
| 23.09. | Innovation in Oncology: The Synergy of New and Old Drugs | ||
| 23.09. | Pelago Unveils New Behavioral Health Platform for Substance Use, Mental Health and Behavioral Addiction Care | ||
| 22.09. | How is Oracle Health's Nurse AI Agent Different? | ||
| 22.09. | Amgen Drug Meets Goals of Key Test in Common Autoimmune Disease With No Approved Meds | ||
| 22.09. | AI Workers Need a Probation Period, Not Just a Pilot | ||
| 21.09. | Radiopharmaceutical Dealmaking Continues With Telix's $1.65B ITM Acquisition | ||
| 21.09. | Array Behavioral Care Unveils New Triage Model | ||
| 21.09. | How AI Is Transforming Clinical Documentation at Intermountain Health | ||
| 21.09. | The Nurse Is Health Care's Most Underpriced Founder | ||
| 21.09. | Electra's Upsized IPO Lands $350M for New Class of Precision Immunology Drugs | ||
| 21.09. | Angle Health Raises $600M to Grow Employer Health Benefits Platform | ||
| 20.09. | RFK Jr. Overhauls USPSTF Leadership: 5 Things to Know | ||
| 20.09. | Two Years After the Change Healthcare Cyberattack, Healthcare Still Has a Clearinghouse Redundancy Problem | ||
| 20.09. | The Trials Were Always There - Patients Just Couldn't Find Them | ||
| 18.09. | Ayble Health Secures $16M for Virtual Digestive Health Clinic | ||
| 18.09. | Ultragenyx Gene Therapy Is First Approved Treatment for Rare Neuro Disease Sanfilippo | ||
| 18.09. | CMS Broadens ACCESS Model to New Chronic Conditions |